Pharmacological and Behavioral Treatments to Treat Loss-of-Control Eating and Improve Weight Outcomes After Bariatric Surgery: Medication Change for Non-Responders (Stage 2b)
Latest Information Update: 08 May 2024
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Eating disorders
- Focus Therapeutic Use
- 02 May 2024 Planned primary completion date changed from 1 May 2026 to 1 May 2027.
- 14 Oct 2021 Status changed from not yet recruiting to recruiting.
- 29 Oct 2020 New trial record